Loading
Latest filing published 10 Apr 2008 for IMMUNICON CORP, €471.
No signal scores available.
James L. Wilcox discloses dealings in Immunicon Corp to SEC (Form 4). The record holds 3 filings, for trades running from 24 January 2007 to 11 March 2008.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The latest filing, published on 10 April 2008, reports a share grant of €471 in Immunicon Corp. Filings reach the SEC (Form 4) feed a median of 30 days after the trade. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations